image
CytomX Therapeutics, Inc. CTMX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.91
-9 %
$ 71.2 M
Market Cap
6.07
P/E
INCOME STATEMENT
101 M REVENUE
90.38%
Growth Rates
1Year 90.38%
3Years 0.28%
5Years 11.21%
7Years 31.30%
10Years 60.58%
-6.48 M OPERATING INCOME
93.60%
Growth Rates
1Year 93.60%
3Years 48.90%
5Years 39.17%
7Years 27.16%
10Years 8.02%
-569 K NET INCOME
99.43%
Growth Rates
1Year 99.43%
3Years 74.14%
5Years 63.23%
7Years 48.46%
10Years 27.97%
EFFICIENCY
Earnings Waterfall CytomX Therapeutics, Inc.
image
Revenue 101 M
Cost Of Revenue 2.18 M
Gross Profit 99 M
Operating Expenses 108 M
Operating Income -6.48 M
Other Expenses -5.92 M
Net Income -569 K

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 101.2 53.2 69.6 100.4 57.5 59.5 71.6 15.0 7.7 5.1 0.9
GROSS PROFIT
Cost Of Revenue 2.2 5.9 5.8 0 0 0 0 0 0 0 0
Gross Profit 99.0 47.3 63.7 100.4 57.5 59.5 71.6 15.0 7.7 5.1 0.9
OPERATING INCOME
Operating Expenses 107.7 154.5 153.4 149.0 168.4 137.4 117.9 74.6 40.9 34.8 15.8
Selling, General and Administrative Expenses 30.0 42.8 39.2 36.0 36.8 33.5 25.6 19.9 12.6 6.5 5.0
Research and Development Expenses 77.7 111.6 114.2 112.9 131.6 103.9 92.3 54.8 28.4 28.3 10.9
Operating Income (6.5) (101.3) (83.8) (48.6) (110.9) (77.9) (46.3) (59.6) (33.2) (29.8) (15.0)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0 0 0 1.7 1.7 0.5 0.3
Total Other Income 9.8 2.0 0.2 1.8 8.2 7.6 2.6 0.7 (2.2) (0.5) (0.2)
Pre-Tax Income 3.3 (99.3) (83.6) (46.8) (102.7) (70.3) (43.6) (58.9) (35.4) (30.3) (15.1)
NET INCOME
Tax Provision 3.9 (2.0) (3.0) (13.9) (0.4) 14.3 (0.5) 19 K 10 K 10 K 10 K
Net Income (0.6) (97.3) (80.6) (32.9) (102.2) (84.6) (43.1) (58.9) (35.4) (30.3) (15.1)
EPS 0.0077 1.48 1.26 0.71 2.26 2.03 1.16 1.63 4.12 0.87 0.43